Day One Biopharmaceuticals Q4 2025 Earnings EPS Misses Estimates as PreRevenue Biotech Advances Pipeline VTGN Q1 2026 Earnings Narrowing Losses as Pipeline Progress Steadies Investor Sentiment CDZI Q1 2026 Earnings NarrowerThanExpected Loss Improves Sentiment RILYT Q1 2024 Earnings Negative EPS Highlights Challenges for Senior Notes Holders HFWA Q1 2026 Earnings Net Interest Margin Stability Drives Earnings Beat Virgin Galactic SPCE Q1 2026 Earnings NarrowerThanExpected Loss Lifts Shares